1. Home
  2. LEGN vs AES Comparison

LEGN vs AES Comparison

Compare LEGN & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • AES
  • Stock Information
  • Founded
  • LEGN 2014
  • AES 1981
  • Country
  • LEGN United States
  • AES United States
  • Employees
  • LEGN N/A
  • AES N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • AES Electric Utilities: Central
  • Sector
  • LEGN Health Care
  • AES Utilities
  • Exchange
  • LEGN Nasdaq
  • AES Nasdaq
  • Market Cap
  • LEGN 6.3B
  • AES 10.3B
  • IPO Year
  • LEGN 2020
  • AES 1991
  • Fundamental
  • Price
  • LEGN $31.98
  • AES $14.60
  • Analyst Decision
  • LEGN Strong Buy
  • AES Hold
  • Analyst Count
  • LEGN 12
  • AES 9
  • Target Price
  • LEGN $70.82
  • AES $13.63
  • AVG Volume (30 Days)
  • LEGN 1.4M
  • AES 12.9M
  • Earning Date
  • LEGN 11-11-2025
  • AES 11-04-2025
  • Dividend Yield
  • LEGN N/A
  • AES 4.83%
  • EPS Growth
  • LEGN N/A
  • AES 8.40
  • EPS
  • LEGN N/A
  • AES 1.28
  • Revenue
  • LEGN $796,838,000.00
  • AES $12,032,000,000.00
  • Revenue This Year
  • LEGN $70.27
  • AES $2.67
  • Revenue Next Year
  • LEGN $50.28
  • AES $4.34
  • P/E Ratio
  • LEGN N/A
  • AES $11.30
  • Revenue Growth
  • LEGN 74.75
  • AES N/A
  • 52 Week Low
  • LEGN $27.34
  • AES $9.46
  • 52 Week High
  • LEGN $47.79
  • AES $17.98
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.50
  • AES 58.16
  • Support Level
  • LEGN $30.77
  • AES $14.05
  • Resistance Level
  • LEGN $34.80
  • AES $14.89
  • Average True Range (ATR)
  • LEGN 1.52
  • AES 0.48
  • MACD
  • LEGN 0.17
  • AES 0.03
  • Stochastic Oscillator
  • LEGN 30.02
  • AES 63.98

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About AES The AES Corporation

AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.

Share on Social Networks: